Skip to search formSkip to main contentSkip to account menu

OXT-328

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Organophosphorus CompoundsSulindac
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
cacy of topical P-S hydrogel in the treatment of non-melanoma skin cancer in preclinical models. P-S is a potent inhibitor of A431 epidermoid carcinoma in vitro and achieves this effect by inhibiting…
Phospho-sulindac (P-S, OXT-328), a novel sulindac derivative, has shown superior anticancer efficacy and safety compared to…